Teleflex Incorporated (TFX) Holdings Trimmed by Raymond James & Associates

Raymond James & Associates decreased its holdings in Teleflex Incorporated (NYSE:TFX) by 6.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,859 shares of the medical technology company’s stock after selling 3,066 shares during the period. Raymond James & Associates’ holdings in Teleflex were worth $11,412,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the business. BlackRock Inc. increased its stake in Teleflex by 3.4% in the fourth quarter. BlackRock Inc. now owns 4,709,341 shares of the medical technology company’s stock worth $1,171,779,000 after purchasing an additional 156,527 shares during the period. American Century Companies Inc. increased its stake in Teleflex by 24.1% in the fourth quarter. American Century Companies Inc. now owns 1,474,609 shares of the medical technology company’s stock worth $366,912,000 after purchasing an additional 286,700 shares during the period. Geode Capital Management LLC increased its stake in Teleflex by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 398,866 shares of the medical technology company’s stock worth $99,192,000 after purchasing an additional 9,515 shares during the period. Renaissance Technologies LLC increased its stake in Teleflex by 511.6% in the fourth quarter. Renaissance Technologies LLC now owns 195,700 shares of the medical technology company’s stock worth $48,694,000 after purchasing an additional 163,700 shares during the period. Finally, Bamco Inc. NY increased its stake in shares of Teleflex by 38.4% during the fourth quarter. Bamco Inc. NY now owns 189,785 shares of the medical technology company’s stock valued at $47,222,000 after buying an additional 52,645 shares during the period. Institutional investors and hedge funds own 90.75% of the company’s stock.

How to Become a New Pot Stock Millionaire

In related news, VP John Deren sold 1,359 shares of the firm’s stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $255.67, for a total transaction of $347,455.53. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $248.96, for a total value of $49,792.00. Following the sale, the director now directly owns 8,080 shares in the company, valued at approximately $2,011,596.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,259 shares of company stock worth $3,760,536. 2.39% of the stock is owned by corporate insiders.

Several equities analysts have recently commented on the company. Leerink Swann restated a “buy” rating and set a $321.00 price target (up previously from $307.00) on shares of Teleflex in a research note on Tuesday, January 30th. ValuEngine lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Stephens restated a “buy” rating and set a $300.00 price target on shares of Teleflex in a research note on Thursday, January 18th. Finally, TheStreet lowered Teleflex from an “a-” rating to a “c+” rating in a research note on Monday, March 12th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $281.56.

TFX stock opened at $252.86 on Friday. The company has a market capitalization of $11,569.10, a price-to-earnings ratio of 30.57, a PEG ratio of 1.90 and a beta of 1.22. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.51 and a current ratio of 2.33. Teleflex Incorporated has a 52 week low of $191.04 and a 52 week high of $288.78.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $2.44 earnings per share for the quarter, beating analysts’ consensus estimates of $2.40 by $0.04. Teleflex had a return on equity of 16.46% and a net margin of 7.11%. The company had revenue of $595.10 million for the quarter, compared to the consensus estimate of $601.17 million. During the same quarter last year, the company earned $2.13 earnings per share. The firm’s revenue for the quarter was up 15.8% compared to the same quarter last year. analysts forecast that Teleflex Incorporated will post 9.65 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 15th. Investors of record on Friday, March 2nd were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.54%. The ex-dividend date of this dividend was Thursday, March 1st. Teleflex’s payout ratio is currently 41.59%.

TRADEMARK VIOLATION WARNING: This news story was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/3296854/teleflex-incorporated-tfx-holdings-trimmed-by-raymond-james-associates.html.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

MutualFirst Financial Inc.  Expected to Announce Quarterly Sales of $19.45 Million
MutualFirst Financial Inc. Expected to Announce Quarterly Sales of $19.45 Million
Acacia Mining  Rating Increased to Sell at Citigroup
Acacia Mining Rating Increased to Sell at Citigroup
$1.89 Billion in Sales Expected for Campbell Soup  This Quarter
$1.89 Billion in Sales Expected for Campbell Soup This Quarter
Barclays  Stock Rating Upgraded by Berenberg Bank
Barclays Stock Rating Upgraded by Berenberg Bank
Credit Suisse Group Analysts Give Fraport AG Frankfurt Arprt Svcs Wrldwde  a €86.00 Price Target
Credit Suisse Group Analysts Give Fraport AG Frankfurt Arprt Svcs Wrldwde a €86.00 Price Target
Peel Hunt Reiterates Hold Rating for Bovis Homes Group
Peel Hunt Reiterates Hold Rating for Bovis Homes Group


© 2006-2018 Ticker Report. Google+.